View Older Stories View More Recent Stories

May 15, 2025 04:59PM Form SCHEDULE 13G/A NewAmsterdam Pharma Co Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:58PM Form SCHEDULE 13G/A GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:57PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:56PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:56PM Form SCHEDULE 13G/A Surrozen, Inc./DE Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:56PM Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:54PM Form SCHEDULE 13G/A UroGen Pharma Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:54PM Form SCHEDULE 13G/A CHIMERIX INC Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:53PM Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:53PM Form SCHEDULE 13G/A Vaxcyte, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:53PM Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:51PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:50PM Form SCHEDULE 13G/A Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:49PM Form SCHEDULE 13G/A Adagio Medical Holdings, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2025 04:45PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 14, 2025 06:34PM Form SCHEDULE 13D/A iTeos Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
May 14, 2025 06:09PM Form SCHEDULE 13D/A Werewolf Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
May 13, 2025 07:00AM Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full Potential of CAR-T Therapy
May 9, 2025 04:19PM Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 30, 2025 04:52PM Form SCHEDULE 13D/A Jade Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 28, 2025 04:35PM Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Apr 28, 2025 03:00PM Adela Presents Data Demonstrating Ability of Tissue-Free MRD Test to Predict Recurrence in Lung Cancer at the American Association for Cancer Research Annual Meeting 2025
Apr 28, 2025 10:18AM Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
Apr 25, 2025 01:00PM T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Apr 24, 2025 09:00AM Report: Washington State’s $41.2B Life Sciences Industry Grew 50% Over Past Decade
Apr 11, 2025 09:00AM Adela's Co-Founder & Chief Scientific Officer, Dr. Daniel De Carvalho, Receives 2025 Canada Gairdner Momentum Award Recognizing World-Renowned Scientists for Exceptional Scientific Research Contri
Apr 10, 2025 08:00AM Imbria Pharmaceuticals Raises $57.5M Series B Financing Round and Appoints Alvin Shih, MD as CEO
Apr 4, 2025 04:32PM Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 2, 2025 06:23AM Edgewise Therapeutics Inc. (EWTX) Announces Pricing of $200M Underwritten Offering of Common Stock
Apr 2, 2025 06:22AM Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock
Mar 31, 2025 04:57PM Form SCHEDULE 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 31, 2025 04:54PM Form SCHEDULE 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 25, 2025 04:30PM T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
Mar 24, 2025 09:01AM Surrozen (SRZN) Announces Oversubscribed $175M Private Placement
Mar 24, 2025 09:00AM Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases   
Mar 20, 2025 04:05PM Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
Mar 17, 2025 07:58PM Form SCHEDULE 13D/A Mineralys Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 17, 2025 08:00AM Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Mar 17, 2025 08:00AM Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
Mar 12, 2025 06:00AM Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway
Mar 10, 2025 04:33PM Form SCHEDULE 13D/A Janux Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 6, 2025 04:35PM Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Mar 3, 2025 08:17PM Form SCHEDULE 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 3, 2025 09:00AM Be Biopharma Announces Appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer
Feb 21, 2025 04:15PM Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 21, 2025 06:12AM Weekly Roundup: 12 Finance Press Releases You Need to See
Feb 20, 2025 08:00AM T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors
Feb 18, 2025 04:25PM Form SCHEDULE 13D Sionna Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 18, 2025 07:01AM Solid Biosciences (SLDB) Prices 35.74M Share Offering at $4.03/sh
Feb 18, 2025 07:00AM Solid Biosciences Announces Pricing of Underwritten Offering
View More Recent Stories View Older Stories